Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia : results of the EP...
Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia : results of the EPIC study
About this item
Full title
Author / Creator
ROJAS, J. M , KNIGHT, K , WANG, L and CLARK, R. E
Publisher
London: Nature Publishing
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing
Subjects
More information
Scope and Contents
Contents
Peptides from the e14a2 BCR-ABL junction will elicit T-cell responses in vitro. Here, 19 imatinib treated CML patients in first chronic phase were vaccinated with BCR-ABL peptides spanning the e14a2 fusion junction, some of which were linked to the pan DR epitope PADRE to augment CD4+ T cell help. Six vaccinations were given over 9 weeks, together...
Alternative Titles
Full title
Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia : results of the EPIC study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_817604045
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_817604045
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/sj.leu.2404858
